posted on 2015-05-06, 00:00authored byMo Jiang, Charles
D. Papageorgiou, Josh Waetzig, Andrew Hardy, Marianne Langston, Richard D. Braatz
Continuous-flow solution crystallization
is an approach to manufacture
pharmaceutical crystals with improved control of product characteristics,
simplified postcrystallization operations, higher production rate
flexibility, and reduced capital costs and footprint. An indirect
ultrasonication-assisted nucleation process is designed to vary the
seed generation rate during operation independent of mass flow rate,
by varying the ultrasonication power. The ultrasonication probe is
pressed against a tube to generate a spatially localized zone within
the tube inside of a temperature bath for the generation of crystal
nuclei without heating or contaminating the supersaturated solution.
This nucleation design is integrated into a continuous slug-flow crystallization
process to generate uniform-sized product crystals within each slug
at a high supersaturation level and a short residence time of ∼8.5
min, without inducing significant secondary nucleation. By increasing
size uniformity, the indirect ultrasonication-assisted slug-flow crystallizer
has potential as a final crystallization step to produce crystals
for direct compression tableting without having any possibility of
metal contamination.